Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
These are the same general criteria used in the approved indication for Wegovy and in the FDA labeling for GLP-1 drugs for cardiovascular risk reduction
The minimum recommended gap between cycles is four months
For most people seeking weight loss without established cardiovascular disease, Tirzepatide represents the better choice
In September, just two months after Caremark stopped covering Zepbound, patients filed a class-action lawsuit against CVS over the decision, arguing that while the Woonsocket company was willing to cover Wegovy, the two drugs were not medically interchangeable
Although there was no significant difference between groups, our study observed weight regain only in the subgroup of higher level of weight loss compared with the control group
